| An attempt to prevent senescence: a mitochondrial approach VP Skulachev, VN Anisimov, YN Antonenko, LE Bakeeva, BV Chernyak, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1787 (5), 437-461, 2009 | 572 | 2009 |
| Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice VN Anisimov, LM Berstein, PA Egormin, TS Piskunova, IG Popovich, ... Experimental gerontology 40 (8-9), 685-693, 2005 | 537 | 2005 |
| Melatonin as antioxidant, geroprotector and anticarcinogen VN Anisimov, IG Popovich, MA Zabezhinski, SV Anisimov, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1757 (5-6), 573-589, 2006 | 420 | 2006 |
| Metformin slows down aging and extends life span of female SHR mice VN Anisimov, LM Berstein, PA Egormin, TS Piskunova, IG Popovich, ... Cell cycle 7 (17), 2769-2773, 2008 | 407 | 2008 |
| Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice VN Anisimov, MA Zabezhinski, IG Popovich, TS Piskunova, ... Cell cycle 10 (24), 4230-4236, 2011 | 387 | 2011 |
| If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice VN Anisimov, LM Berstein, IG Popovich, MA Zabezhinski, PA Egormin, ... Aging (Albany NY) 3 (2), 148, 2011 | 331 | 2011 |
| Rapamycin extends maximal lifespan in cancer-prone mice VN Anisimov, MA Zabezhinski, IG Popovich, TS Piskunova, ... The American journal of pathology 176 (5), 2092-2097, 2010 | 285 | 2010 |
| Peptide bioregulation of aging: results and prospects VN Anisimov, VK Khavinson Biogerontology 11 (2), 139-149, 2010 | 284 | 2010 |
| Carcinogenesis and aging VN Anisimov, NN Petrov CRC Press Inc., Boca Raton, FL, 1987 | 267* | 1987 |
| The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer VN Anisimov, A Bartke Critical reviews in oncology/hematology 87 (3), 201-223, 2013 | 254 | 2013 |
| Cancer in rodents: does it tell us about cancer in humans? VN Anisimov, SV Ukraintseva, AI Yashin Nature Reviews Cancer 5 (10), 807-819, 2005 | 246 | 2005 |
| Effect of Treatment with Phenformin, Diphenylhydantoin or L-Dòpa on Life Span and Tumour Incidence in C3H/Sn Mice VM Dilman, VN Anisimov Gerontology 26 (5), 241-246, 1980 | 233 | 1980 |
| Carcinogenicity of night shift work EM Ward, D Germolec, M Kogevinas, D McCormick, R Vermeulen, ... The lancet oncology 20 (8), 1058-1059, 2019 | 227 | 2019 |
| Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies M V Skulachev, Y N Antonenko, V N Anisimov, B V Chernyak, ... Current drug targets 12 (6), 800-826, 2011 | 225 | 2011 |
| Metformin for aging and cancer prevention VN Anisimov Aging (Albany NY) 2 (11), 760, 2010 | 222 | 2010 |
| Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo VN Anisimov, PA Egormin, TS Piskunova, IG Popovich, ML Tyndyk, ... Cell Cycle 9 (1), 188-197, 2010 | 221 | 2010 |
| Molekulyarnye i fiziologicheskie mekhanizmy stareniya (Molecular and Physiological Mechanisms of Aging) VN Anisimov St. Petersburg: Nauka, 2008 | 211 | 2008 |
| Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1, 2-dimethylhydrazine in rats. VN Anisimov, IG Popovich, MA Zabezhinski Carcinogenesis 18 (8), 1549-1553, 1997 | 172 | 1997 |
| Molecular and physiological mechanisms of aging VN Anisimov Saint Petersburg: Nauka 1, 481, 2008 | 164 | 2008 |
| Metformin: do we finally have an anti-aging drug? VN Anisimov Cell cycle 12 (22), 3483-3489, 2013 | 161 | 2013 |
